Hosted on MSN

DexCom reports strong Q1 as OTC CGMs reach new users

DexCom posted better-than-expected Q1 2026 results, with revenue up 15% year-over-year on strong uptake of its G7 continuous glucose monitor and expanded coverage for type 2 diabetes patients not ...
MarketBeat on MSN

3 reasons analysts love DexCom

While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a ...

Wearables for Blood Sugar Tracking: What Works Now and What’s Still Coming

Compare Apple Watch, Garmin, Oura, Samsung, Withings, Huawei, and Evie Ring in the race to bring blood sugar data to ...
Barron's

DexCom Inc.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...
Drug Delivery Business

Tandem makes t:slim X2 insulin pump available with Dexcom G7 15 Day CGM

Tandem Diabetes Care (Nasdaq:TNDM) announced that it made its t:slim X2 insulin pump available with the Dexcom (Nasdaq:DXCM) ...